[{"id":"9414e6bb-d90c-48a4-9277-b07aefc72016","acronym":"","url":"https://clinicaltrials.gov/study/NCT05341947","created_at":"2022-04-22T13:53:40.793Z","updated_at":"2024-07-02T16:36:11.600Z","phase":"Phase 1","brief_title":"Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma","source_id_and_acronym":"NCT05341947","lead_sponsor":"Jeremy Rudnick, M.D","biomarkers":" HER-2 • IL13RA2","pipe":" | ","alterations":" CD133 expression • HLA-A2 positive","tags":["HER-2 • IL13RA2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD133 expression • HLA-A2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KROS-201"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 06/01/2022","start_date":" 06/01/2022","primary_txt":" Primary completion: 06/01/2023","primary_completion_date":" 06/01/2023","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2022-04-22"},{"id":"1f19e7e7-759e-4e9a-bdaa-aa15810ed49c","acronym":"","url":"https://clinicaltrials.gov/study/NCT04873154","created_at":"2021-05-05T11:52:34.602Z","updated_at":"2024-07-02T16:36:30.526Z","phase":"","brief_title":"CD133 Expression in Mammary Invasive Ductal Carcinoma","source_id_and_acronym":"NCT04873154","lead_sponsor":"Sohag University","biomarkers":" ","pipe":" | ","alterations":" CD133 expression","tags":["CD133 expression"],"overall_status":"Recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 05/01/2021","start_date":" 05/01/2021","primary_txt":" Primary completion: 11/01/2021","primary_completion_date":" 11/01/2021","study_txt":" Completion: 12/01/2021","study_completion_date":" 12/01/2021","last_update_posted":"2021-05-10"},{"id":"0c5c48ba-d7d3-4f6f-bfea-aa634fc92bbd","acronym":"","url":"https://clinicaltrials.gov/study/NCT04137627","created_at":"2021-01-18T20:12:25.557Z","updated_at":"2024-07-02T16:36:52.790Z","phase":"Phase 3","brief_title":"Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma","source_id_and_acronym":"NCT04137627","lead_sponsor":"Indonesia University","biomarkers":" HIF1A • CD44","pipe":" | ","alterations":" CD44 expression • CD133 expression • HIF1A expression","tags":["HIF1A • CD44"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD44 expression • CD133 expression • HIF1A expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin"],"overall_status":"Completed","enrollment":" Enrollment 50","initiation":"Initiation: 07/04/2017","start_date":" 07/04/2017","primary_txt":" Primary completion: 07/30/2018","primary_completion_date":" 07/30/2018","study_txt":" Completion: 12/18/2018","study_completion_date":" 12/18/2018","last_update_posted":"2019-12-09"},{"id":"e722bb9a-1b52-491f-aa47-aef3ea3920fe","acronym":"STEMRI","url":"https://clinicaltrials.gov/study/NCT01872221","created_at":"2021-01-18T08:23:11.135Z","updated_at":"2024-07-02T16:37:07.485Z","phase":"","brief_title":"Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study","source_id_and_acronym":"NCT01872221 - STEMRI","lead_sponsor":"Institut Claudius Regaud","biomarkers":" SOX2 • OLIG2","pipe":" | ","alterations":" CD133 expression","tags":["SOX2 • OLIG2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD133 expression"],"overall_status":"Completed","enrollment":" Enrollment 21","initiation":"Initiation: 05/01/2013","start_date":" 05/01/2013","primary_txt":" Primary completion: 04/01/2018","primary_completion_date":" 04/01/2018","study_txt":" Completion: 04/01/2018","study_completion_date":" 04/01/2018","last_update_posted":"2018-08-27"},{"id":"e94f4f58-1623-4f47-9209-85549c7b232d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03002727","created_at":"2021-01-18T14:46:14.034Z","updated_at":"2024-07-02T16:37:10.899Z","phase":"","brief_title":"Role of CD133 \u0026 Microsatellite Status in Evaluation of Rectosigmoid Cancer Young Adults Received Neoadjuvant Treatment","source_id_and_acronym":"NCT03002727","lead_sponsor":"Assiut University","biomarkers":" ","pipe":" | ","alterations":" CD133 expression","tags":["CD133 expression"],"overall_status":"Unknown status","enrollment":" Enrollment 30","initiation":"Initiation: 12/01/2016","start_date":" 12/01/2016","primary_txt":" Primary completion: 12/01/2018","primary_completion_date":" 12/01/2018","study_txt":" Completion: 01/01/2019","study_completion_date":" 01/01/2019","last_update_posted":"2018-05-08"}]